Shattuck Labs, Inc. STTK
4.99 USD +0.37 (+8.01%)
At closeNov 9, 2026, 4:01 PM EST
4.99 0.00 0.00%
After hours · Nov 9, 4:01 PM ET
4.54 Day range 5.05
1.72 52-week range 8.33
- YTD
- +36.71%
- 1 year
- +152.02%
News
globenewswire.com Shattuck Labs Reports Third Quarter 2026 Financial Results and Recent Business Highlights – Initiated the RECEPTIVE-CD1 Phase 2b clinical trial of SL-325 in Crohn's disease; 12-week induction data expected in the first half of 2028 – – Announced RECEPTIVE-HS1 Phase 2 clinical trial of…
benzinga.com UBS Initiates Coverage On Shattuck Labs with Buy Rating, Announces Price Target of $17 UBS analyst Alice Nettleton initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Buy rating and announces Price Target of $17.
benzinga.com Wedbush Maintains Outperform on Shattuck Labs, Raises Price Target to $14 Wedbush analyst David Nierengarten maintains Shattuck Labs (NASDAQ:STTK) with a Outperform and raises the price target from $11 to $14.
benzinga.com Abbott To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Friday Analysts raised targets for ACN, SYNA, ATRC and MPC; cut targets for CSX, NKE, MKC and FHTX, with ATRC downgraded to Hold.- benzinga.com Needham Maintains Buy on Shattuck Labs, Raises Price Target to $19 Needham analyst Joseph Stringer maintains Shattuck Labs (NASDAQ:STTK) with a Buy and raises the price target from $17 to $19.
benzinga.com Raymond James Initiates Coverage On Shattuck Labs with Strong Buy Rating, Announces Price Target of $18 Raymond James analyst Martin Auster initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Strong Buy rating and announces Price Target of $18.
benzinga.com HC Wainwright & Co. Maintains Buy on Shattuck Labs, Lowers Price Target to $14 HC Wainwright & Co. analyst Joseph Pantginis maintains Shattuck Labs (NASDAQ:STTK) with a Buy and lowers the price target from $18 to $14.
benzinga.com Shattuck Labs Q2 EPS $(0.12) Misses $(0.10) Estimate Shattuck Labs (NASDAQ:STTK) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) by 20 percent. This is a 50 percent increase over losses of $(0.24)…
benzinga.com This Shattuck Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday Wall Street analysts changed outlook on top names. For full changes, upgrades, downgrades and initiations, see analyst ratings page.
benzinga.com JP Morgan Initiates Coverage On Shattuck Labs with Overweight Rating, Announces Price Target of $10 JP Morgan analyst Brian Cheng initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Overweight rating and announces Price Target of $10.- benzinga.com Leerink Partners Initiates Coverage On Shattuck Labs with Outperform Rating, Announces Price Target of $16 Leerink Partners analyst Faisal Khurshid initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Outperform rating and announces Price Target of $16.
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session 
benzinga.com Rezolve AI, Bakkt, Seagate And Other Big Stocks Moving Higher On Friday U.S. stocks were mixed, with the Dow Jones gaining 100 points. Rezolve AI (RZLV) jumped 11.9%, and other stocks such as ALOY and FWRD also rose.
benzinga.com What's Going On With Shattuck Labs Stock Wednesday? Shattuck Labs ($STTK) shares fluctuate after pricing a $75M public offering at $4.00/share. Get the latest stock updates here.
benzinga.com Shattuck Labs Commences Common Stock Offering; Terms Undisclosed Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3 blocking…- benzinga.com Citigroup Maintains Buy on Shattuck Labs, Raises Price Target to $18 Citigroup analyst Yigal Nochomovitz maintains Shattuck Labs (NASDAQ:STTK) with a Buy and raises the price target from $7 to $18.
- benzinga.com Shattuck Labs Announces Total Expected Proceeds Of ~$59.4M From Exercised Warrants Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3-blocking antibodies for the…
benzinga.com Why Is Shattuck Labs Stock Trading Lower On Monday? Shattuck Labs' stock tumbles after Phase 1 SL-325 data release despite analyst upgrades, a Buy consensus rating, and progress in IBD treatment.
benzinga.com Crude Oil Gains Over 1%; Motorcar Parts Of America Shares Surge After Q4 Earnings US stocks rose with Nasdaq up 400 points. Dow up 0.32%, Nasdaq up 1.55%, S&P 500 up 0.94%. Tech shares rose, communication services fell. Motorcar Parts of America stock jumped 37% on strong…- benzinga.com Needham Maintains Buy on Shattuck Labs, Raises Price Target to $17 Needham analyst Joseph Stringer maintains Shattuck Labs (NASDAQ:STTK) with a Buy and raises the price target from $14 to $17.
- benzinga.com HC Wainwright & Co. Reiterates Buy on Shattuck Labs, Maintains $18 Price Target HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $18 price target.
benzinga.com Shattuck Reports Phase 1 Data for SL-325 Antibody Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of potential first-in-class monoclonal and bispecific DR3 blocking…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session - benzinga.com Shattuck Labs To Host Investor Call And Webcast On June 8 To Present Comprehensive Phase 1 Clinical Data For SL-325 And Provide Pipeline Update Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3-blocking antibodies for the…
benzinga.com Citigroup Upgrades Shattuck Labs to Buy, Announces $7 Price Target Citigroup analyst Yigal Nochomovitz upgrades Shattuck Labs (NASDAQ:STTK) from Neutral to Buy and announces $7 price target.
benzinga.com Merlin, Concrete Pumping Holdings, And Krispy Kreme And Other Big Stocks Moving Higher On Friday U.S. stocks trade lower on Friday, Nasdaq down 425 points. Merlin shares rise 35.93% after successful CDR, other big stocks also record gains.
benzinga.com Concrete Pumping Holdings Reports Blowout Q2 Results, Joins ServiceTitan and Other Big Stocks Moving Higher in Friday's Pre-Market Session US stock futures higher, Nasdaq futures down. Concrete Pumping Holdings shares up 28.94% pre-market. Other stocks moving in pre-market.- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Wedbush Maintains Outperform on Shattuck Labs, Raises Price Target to $11 Wedbush analyst David Nierengarten maintains Shattuck Labs (NASDAQ:STTK) with a Outperform and raises the price target from $8 to $11.
benzinga.com Shattuck Labs Q1 EPS $(0.13), Inline Shattuck Labs (NASDAQ:STTK) reported quarterly losses of $(0.13) per share which met the analyst consensus estimate. This is a 51.85 percent increase over losses of $(0.27) per share from the same…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket Shares of Nxu, Inc. (NASDAQ: NXU) rose sharply in pre-market trading after the company signed a letter of intent outlining investment in Lynx Motors. Nxu, shares rose 42.1% to $0.0278 in pre-market…
- benzinga.com Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700…
- benzinga.com Earnings Scheduled For November 9, 2023 Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 647 companies set new 52-week lows.
- benzinga.com Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.
- benzinga.com Why Biophytis Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket Gainers FaZe Holdings Inc. (NASDAQ: FAZE) shares rose 64.7% to $0.2520 in pre-market trading after falling over 4% on Friday.